Vitamin D status and physical performance, muscular strength and mass in older adults with sarcopenia

Authors

  • M. A. Hordina Sumy State University, Ukraine,
  • V. F. Orlovskyi Sumy State University, Ukraine,
  • A. V. Zharkova Sumy State University, Ukraine,
  • T. M. Rudenko Sumy State University, Ukraine,
  • D. V. Levchenko Sumy State University, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2020.1.194492

Keywords:

vitamin D, sarcopenia, muscle strength, dynamometer, organ weight, muscle function, walking

Abstract

 

The purpose of the study: to assess the level of vitamin D in older adults (age ≥60 years) with sarcopenia. To analyze the relationship between concentration of 25(OH)D and muscular strength, muscle mass, physical activity and markers of low grade inflammation in patients with sarcopenia.

Material and methods. 76 persons aged 60 to 88 years old were examined. Muscular strength was estimated using grip strength. Physical performance was studied as a gait speed on distance of4 m. Muscle mass was detected by calf circumference (CC) measurement – cut-off point less than35 cm in men and less than33 cm in women estimated for muscle mass insufficiency. Severe sarcopenia was established in case of decrease in all three parameters. Vitamin D concentration was defined as a 25(OH)D level.

Results. After the examination, patients were divided into 2 groups according to the severity of sarcopenia. Among 76 examined patients, signs of severe sarcopenia were diagnosed in 36 cases (47.4 %), older persons (>75 years) prevailed in this group (P = 0.002). Patients with severe sarcopenia had a significantly lower 25(OH)D level (41.1 ± 2.74 nmol/L vs 51.7 ± 2.49 nmol/L, P = 0.005), they were more frequently recognized with obesity, and had significantly lower results in grip strength, muscle mass and gait speed simultaneously with higher level of subclinical inflammation. A significant positive correlation between the level of 25(OH)D and the results of dynamometry, CC, gait speed and significant reverse correlation with the levels of CRP, IL-6 and TNF-α (P < 0.05) was found. Patients with the most pronounced hypovitaminosis D (22.4–30.4 nmol/L) more frequently showed a severe sarcopenia and the lowest rates of muscle strength, mass and function, and the highest level of subclinical inflammation comparing to the patients with 25(OH)D level higher than 61.2 nmol/L.

Conclusions. Severe sarcopenia was detected in 47.4 %, it was registered more frequently in older adults (≥75 years) and patients with obesity. Sarcopenia was associated with hypovitaminosis D and subclinical inflammation. Patients with severe sarcopenia had more pronounced 25(OH)D deficiency. The vitamin D concentration was correlated with indicators of muscular strength and mass, physical activity, as well as markers of subclinical inflammation.

References

Beard, J. R., Officer, A., de Carvalho, I. A., Sadana, R., Pot, A. M., Michel, J. P., Lloyd-Sherlock, P., Epping-Jordan, J. E., Peeters, G. M. E. E. G., Mahanani, W. R., Thiyagarajan, J. A., & Chatterji, S. (2016). The World report on ageing and health: a policy framework for healthy ageing. The Lancet, 387(10033), 2145-2154. https://doi.org/10.1016/s0140-6736(15)00516-4

Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), & the Extended Group for EWGSOP2. (2018). Sarcopenia: revised European consensus on definition and diagnosis. Age And Ageing, 48(1), 16-31. https://doi.org/10.1093/ageing/afy169

Wilkinson, D., Piasecki, M., & Atherton, P. (2018). The age-related loss of skeletal muscle mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans. Ageing Research Reviews, 47, 123-132. https://doi.org/10.1016/j.arr.2018.07.005

Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J., Boirie, Y., Cederholm, T., & Landi, F., Martin, F. C., Michel, J. P., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M., Zamboni, M.; & European Working Group on Sarcopenia in Older People. (2010). Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age And Ageing, 39(4), 412-423. https://doi.org/10.1093/ageing/afq034

Kim, T., & Choi, K. (2013). Sarcopenia: Definition, Epidemiology, and Pathophysiology. Journal Of Bone Metabolism, 20(1), 1-10. https://doi.org/10.11005/jbm.2013.20.1.1

Ramason, R., Selvaganapathi, N., Ismail, N., Wong, W., Rajamoney, G., & Chong, M. (2014). Prevalence of Vitamin D Deficiency in Patients With Hip Fracture Seen in an Orthogeriatric Service in Sunny Singapore. Geriatric Orthopaedic Surgery & Rehabilitation, 5(2), 82-86. https://doi.org/10.1177/2151458514528952

Kim, J., Lee, Y., Kye, S., Chung, Y., & Lee, O. (2016). Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008-2010. Journal Of Cachexia, Sarcopenia And Muscle, 8(2), 259-266. https://doi.org/10.1002/jcsm.12154

Rondanelli, M., Faliva, M., Monteferrario, F., Peroni, G., Repaci, E., Allieri, F., & Perna, S. (2015). Novel Insights on Nutrient Management of Sarcopenia in Elderly. Biomed Research International, 2015. https://doi.org/10.1155/2015/524948

Ju, S., Lee, J., & Kim, D. (2018). Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis. BMC Geriatrics, 18(1). https://doi.org/10.1186/s12877-018-0904-2

Gunton, J., & Girgis, C. (2018). Vitamin D and muscle. Bone Reports, 8, 163-167. https://doi.org/10.1016/j.bonr.2018.04.004

Wagatsuma, A., & Sakuma, K. (2014). Vitamin D Signaling in Myogenesis: Potential for Treatment of Sarcopenia. Biomed Research International, 2014. https://doi.org/10.1155/2014/121254

Molina, P., Carrero, J., Bover, J., Chauveau, P., Mazzaferro, S., & Torres, P. (2017). Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. Journal Of Cachexia, Sarcopenia And Muscle, 8(5), 686-701. https://doi.org/10.1002/jcsm.12218

Bahat, G., Yilmaz, O., Oren, M., Karan, M., Reginster, J., Bruyère, O., & Beaudart, C. (2017). Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group. European Geriatric Medicine, 9, 23-28. https://doi.org/10.1007/s41999-017-0003-5

Bahat, G., Yilmaz, O., Kiliç, C., Oren, M., & Karan, M. (2018). Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures. The Journal Of Nutrition, Health & Aging, 22, 898-903. https://doi.org/10.1007/s12603-018-1067-8

Ibrahim, K., May, C., Patel, H., Baxter, M., Sayer, A., & Roberts, H. (2018). Implementation of grip strength measurement in medicine for older people wards as part of routine admission assessment: identifying facilitators and barriers using a theory-led intervention. BMC Geriatrics, 18. https://doi.org/10.1186/s12877-018-0768-5

Kim, S., Kim, M., Lee, Y., Kim, B., Yoon, T., & Won, C. (2018). Calf Circumference as a Simple Screening Marker for Diagnosing Sarcopenia in Older Korean Adults: the Korean Frailty and Aging Cohort Study (KFACS). Journal Of Korean Medical Science, 33(20), Article e151. https://doi.org/10.3346/jkms.2018.33.e151

Maggio, M., Ceda, G. P., Ticinesi, A., De Vita, F., Gelmini, G., Costantino, C., Meschi, T., Kressig, R. W., Cesari, M., Fabi, M., & Lauretani, F. (2016). Instrumental and Non-Instrumental Evaluation of 4-Meter Walking Speed in Older Individuals. PLOS ONE, 11(4), Article e0153583. https://doi.org/10.1371/journal.pone.0153583

Holick, M. (2017). The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews In Endocrine And Metabolic Disorders, 18(2), 153-165. https://doi.org/10.1007/s11154-017-9424-1

Ethgen, O., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J. (2016). The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcified Tissue International, 100(3), 229-234. https://doi.org/10.1007/s00223-016-0220-9

Choi, K. (2016). Sarcopenia and sarcopenic obesity. The Korean Journal Of Internal Medicine, 31(6), 1054-1060. https://doi.org/10.3904/kjim.2016.193

Beaudart, C., Buckinx, F., Rabenda, V., Gillain, S., Cavalier, E., Slomian, J. Petermans, J., Reginster, J. Y., & Bruyère, O. (2014). The Effects of Vitamin D on Skeletal Muscle Strength, Muscle Mass, and Muscle Power: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal Of Clinical Endocrinology & Metabolism, 99(11), 4336-4345. https://doi.org/10.1210/jc.2014-1742

Bano, G., Trevisan, C., Carraro, S., Solmi, M., Luchini, C., Stubbs, B., Manzato, E., Sergi, G., & Veronese, N. (2017). Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas, 96, 10-15. https://doi.org/10.1016/j.maturitas.2016.11.006

Bian, A., Hu, H., Rong, Y., Wang, J., Wang, J., & Zhou, X. (2017). A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α. European Journal Of Medical Research, 22(1). https://doi.org/10.1186/s40001-017-0266-9

How to Cite

1.
Hordina MA, Orlovskyi VF, Zharkova AV, Rudenko TM, Levchenko DV. Vitamin D status and physical performance, muscular strength and mass in older adults with sarcopenia. Zaporozhye Medical Journal [Internet]. 2020Feb.10 [cited 2024Jun.18];22(1). Available from: http://zmj.zsmu.edu.ua/article/view/194492

Issue

Section

Original research